Ontology highlight
ABSTRACT:
SUBMITTER: Pairo-Castineira E
PROVIDER: S-EPMC10208981 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature
Pairo-Castineira Erola E Rawlik Konrad K Bretherick Andrew D AD Qi Ting T Wu Yang Y Nassiri Isar I McConkey Glenn A GA Zechner Marie M Klaric Lucija L Griffiths Fiona F Oosthuyzen Wilna W Kousathanas Athanasios A Richmond Anne A Millar Jonathan J Russell Clark D CD Malinauskas Tomas T Thwaites Ryan R Morrice Kirstie K Keating Sean S Maslove David D Nichol Alistair A Semple Malcolm G MG Knight Julian J Shankar-Hari Manu M Summers Charlotte C Hinds Charles C Horby Peter P Ling Lowell L McAuley Danny D Montgomery Hugh H Openshaw Peter J M PJM Begg Colin C Walsh Timothy T Tenesa Albert A Flores Carlos C Riancho José A JA Rojas-Martinez Augusto A Lapunzina Pablo P Yang Jian J Ponting Chris P CP Wilson James F JF Vitart Veronique V Abedalthagafi Malak M Luchessi Andre D AD Parra Esteban J EJ Cruz Raquel R Carracedo Angel A Fawkes Angie A Murphy Lee L Rowan Kathy K Pereira Alexandre C AC Law Andy A Fairfax Benjamin B Hendry Sara Clohisey SC Baillie J Kenneth JK
Nature 20230517 7962
Critical illness in COVID-19 is an extreme and clinically homogeneous disease phenotype that we have previously shown<sup>1</sup> to be highly efficient for discovery of genetic associations<sup>2</sup>. Despite the advanced stage of illness at presentation, we have shown that host genetics in patients who are critically ill with COVID-19 can identify immunomodulatory therapies with strong beneficial effects in this group<sup>3</sup>. Here we analyse 24,202 cases of COVID-19 with critical illnes ...[more]